MedTrace Logo

A Mobile Supportive Care App for Patients With Metastatic Lung Cancer

NCT03512015 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-04-30

No results posted yet for this study

Summary

Self-management interventions can help patients and their families care for themselves along the cancer care continuum. This scenario has witnessed the rapid and ongoing growth in mobile technologies, including mobile health (mHealth). LuCApp (Lung Cancer App) is an application developed by researchers and lung cancer clinicians to gather symptom data in real time and to share it with healthcare professionals. This is a 24-week, two-arm, non-blinded multicenter feasibility parallel randomized controlled trial aimed to evaluate the usability and effectiveness of LuCApp vs standard care to improve self-management of symptoms and health related quality of life in lung cancer patients.

Conditions

  • Nonsmall Cell Lung Cancer
  • Small Cell Lung Carcinoma

Interventions

OTHER

The Lung Cancer App - LuCApp

The Intervention Arm receiving LuCApp (The Lung Cancer App) in addition to standard care

OTHER

Standard care

The Standard-of-Care patients receiving following the same schedule identified for LuCApp patients with paper questionnaires during clinic visits, or at home (having received paper questionnaires during the previous visit) or via telephonic interviews with the research team.

Sponsors & Collaborators

  • AdvicePharma srl

    collaborator UNKNOWN

  • Bocconi University

    lead OTHER

Principal Investigators

  • Paolo PP Pedrazzoli, MD · Fondazione IRCCS Policlinico S. Matteo - Pavia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2019-12-31
Completion
2020-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03512015 on ClinicalTrials.gov